News

Under the Act, $1bn was earmarked for qualifying therapeutic discovery projects that treat areas of unmet medical need or prevent, detect or treat chronic or acute diseases and

Huber said that the license granted by California’s Department of Public Health, Food and Drug Branch represents a milestone for the continued development of Huber’s Health & Nutrition

The objective of this extension study was to assess the long-term (24 month) efficacy and safety of two doses of Safinamide (50mg and 100mg once daily tablets) as

Takeda said that TAK-700 is a selective, oral, non-steroidal androgen synthesis inhibitor that in preclinical studies has been shown to selectively bind to and inhibit the enzyme 17,20

Par Pharma has posted a net income of $30.53m for the third quarter 2010, compared to $26.34m for the comparable period in 2009. Operating income was $40.61m, compared

Egberts will replace current CEO Simon Sturge, who will leave the company as per 1 January 2011. Egberts is expected to immediately start working together with Sturge until

Affymax CEO Arlene Morris said that the Therapeutic Discovery Project empowers small biotech companies, like Affymax, by providing needed capital to support breakthrough medical discovery, innovation and job

The grants are related to four of Lipocine’s development programs in hormone replacement therapy, high-risk pregnancy support, oral treatment of progressive glioblastoma multiforme and opioid resistant cough in

The grant, which targets therapeutic discovery projects that show a reasonable potential to result in new therapies to treat areas of unmet medical need or to treat chronic